Givinostat showed a trend of inhibiting Aβ toxicity at concentrations of 50 nM, 100 nM, 150 nM, and 200 nM, with the cell viability of the 100 nM group being superior to that of the 0 nM group (P < 0.05).
← all excerpts
A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice.
1
—
—